Drug-delivering aptamers that can precisely target leukemia stem cells with enhanced potency have been developed. Delivering anticancer drugs with specificity and potency to cancer stem cells is an ...
CINCINNATI, Jan. 13, 2026 /PRNewswire/ -- In a groundbreaking proof-of-concept study, researchers at Cincinnati Children's report success at restoring healthy function to blood-making stem cells that ...
In 2021, the lab of chemical biologist and Nobel Laureate Carolyn Bertozzi, PhD, professor at Stanford University, characterized a new type of cell-surface protein, termed glycoRNAs, that form highly ...
Leukemic stem cells (LSCs) and stemness signatures contribute to minimal residual disease in patients with acute myeloid leukemia (AML), which is associated with an increased risk of relapse. The ...
Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers at the University of Illinois ...
MedPage Today on MSN
CAR7 Gene Therapy Shows Promise in T-Cell ALL
The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...
A Los Angeles boy is being credited with potentially saving the life of his father by donating stem cells to help treat his ...
In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.
Acute lymphoblastic leukemia (ALL) manifests as a malignant transformation and proliferation of lymphoid progenitor cells in the bone marrow, blood and eventually extramedullary sites. While mostly ...
LOS ANGELES (KTLA) — A 9-year-old boy from Los Angeles is being thanked for potentially saving his father’s life by donating stem cells to help treat his leukemia. Stephen Mondek is the youngest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results